ISO 14001:2026 - Environmental management systems — Requirements with guidance for use - Order now!

PRICES include / exclude VAT
>UNE standards>UNE EN ISO 25539-1:2017 - Cardiovascular implants - Endovascular devices - Part 1: Endovascular prostheses (ISO 25539-1:2017) (Endorsed by Asociación Española de Normalización in June of 2017.)
in stockReleased: 2017-06-01
UNE EN ISO 25539-1:2017 - Cardiovascular implants - Endovascular devices - Part 1: Endovascular prostheses (ISO 25539-1:2017) (Endorsed by Asociación Española de Normalización in June of 2017.)

UNE EN ISO 25539-1:2017

Cardiovascular implants - Endovascular devices - Part 1: Endovascular prostheses (ISO 25539-1:2017) (Endorsed by Asociación Española de Normalización in June of 2017.)

Implantes cardiovasculares. Productos endovasculares. Parte 1: Prótesis endovasculares. (ISO 25539-1:2017) (Ratificada por la Asociación Española de Normalización en junio de 2017.)

Format
Availability
Price and currency
English PDF
Immediate download
Printable
199.29 USD
English Hardcopy
In stock
199.29 USD
Standard number:UNE EN ISO 25539-1:2017
Pages:142
Released:2017-06-01
Status:Standard
DESCRIPTION

UNE EN ISO 25539-1:2017

Part 1 of ISO 25539 specifies requirements for the evaluation of endovascular systems (prostheses and delivery systems) and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer, based upon current medical knowledge. Guidance for the development of in vitro test methods is included in an informative annex to this standard. This standard should be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants. This part of ISO 25539 is applicable to endovascular systems used to treat aneurysms, stenoses, or other vascular anomalies or pathologies, or to create shunts between vessels (e.g., creation of transjugular intrahepatic portosystemic shunting (TIPS)). Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Although the other uses of endovascular systems are within the scope of this standard, the specific requirements and testing are not described. Similarly, specific prosthesis configurations (e.g., fenestrated, branched) are within the scope, but specific requirements and testing are not described for these devices.